These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 20550119)

  • 21. Non-peptide oxytocin agonists.
    Pitt GR; Batt AR; Haigh RM; Penson AM; Robson PA; Rooker DP; Tartar AL; Trim JE; Yea CM; Roe MB
    Bioorg Med Chem Lett; 2004 Sep; 14(17):4585-9. PubMed ID: 15357997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modeling of the oxytocin receptor/bioligand interactions.
    Politowska E; Czaplewski C; Ciarkowski J
    Acta Biochim Pol; 1999; 46(3):581-90. PubMed ID: 10698266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a urea bioisostere of a triazole oxytocin antagonist.
    Brown A; Ellis D; Wallace O; Ralph M
    Bioorg Med Chem Lett; 2010 Mar; 20(6):1851-3. PubMed ID: 20172721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational aspects of differences in requirements for oxytocin and vasopressin receptors.
    Oldziej S; Ciarkowski J; Liwo A; Shenderovich MD; Grzonka Z
    J Recept Signal Transduct Res; 1995; 15(1-4):703-13. PubMed ID: 8903974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of some substituted pyrazinopyridoindoles and 3D QSAR studies along with related compounds: piperazines, piperidines, pyrazinoisoquinolines, and diphenhydramine, and its semi-rigid analogs as antihistamines (H1).
    Saxena M; Gaur S; Prathipati P; Saxena AK
    Bioorg Med Chem; 2006 Dec; 14(24):8249-58. PubMed ID: 17010624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(piperidin-1-yl)propyl]indoles: agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B subtype.
    Castro JL; Street LJ; Guiblin AR; Jelley RA; Russell MG; Sternfeld F; Beer MS; Stanton JA; Matassa VG
    J Med Chem; 1997 Oct; 40(22):3497-500. PubMed ID: 9357514
    [No Abstract]   [Full Text] [Related]  

  • 27. (S)-(-)-4-[4-[2-(isochroman-1-yl)ethyl]-piperazin-1-yl] benzenesulfonamide, a selective dopamine D4 antagonist.
    TenBrink RE; Bergh CL; Duncan JN; Harris DW; Huff RM; Lahti RA; Lawson CF; Lutzke BS; Martin IJ; Rees SA; Schlachter SK; Sih JC; Smith MW
    J Med Chem; 1996 Jun; 39(13):2435-7. PubMed ID: 8691438
    [No Abstract]   [Full Text] [Related]  

  • 28. Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists.
    Vu CB; Pan D; Peng B; Kumaravel G; Smits G; Jin X; Phadke D; Engber T; Huang C; Reilly J; Tam S; Grant D; Hetu G; Petter RC
    J Med Chem; 2005 Mar; 48(6):2009-18. PubMed ID: 15771443
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: Identification, stereochemistry and initial SAR.
    Wyatt PG; Allen MJ; Borthwick AD; Davies DE; Exall AM; Hatley RJ; Irving WR; Livermore DG; Miller ND; Nerozzi F; Sollis SL; Szardenings AK
    Bioorg Med Chem Lett; 2005 May; 15(10):2579-82. PubMed ID: 15863320
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.
    Wang T; Zhang Z; Wallace OB; Deshpande M; Fang H; Yang Z; Zadjura LM; Tweedie DL; Huang S; Zhao F; Ranadive S; Robinson BS; Gong YF; Ricarrdi K; Spicer TP; Deminie C; Rose R; Wang HG; Blair WS; Shi PY; Lin PF; Colonno RJ; Meanwell NA
    J Med Chem; 2003 Sep; 46(20):4236-9. PubMed ID: 13678401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, synthesis, and biological activities of pyrrolylethanoneamine derivatives, a novel class of monoamine oxidases inhibitors.
    Di Santo R; Costi R; Roux A; Artico M; Befani O; Meninno T; Agostinelli E; Palmegiani P; Turini P; Cirilli R; Ferretti R; Gallinella B; La Torre F
    J Med Chem; 2005 Jun; 48(13):4220-3. PubMed ID: 15974574
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The synthesis and biological evaluation of quinolyl-piperazinyl piperidines as potent serotonin 5-HT1A antagonists.
    Childers WE; Havran LM; Asselin M; Bicksler JJ; Chong DC; Grosu GT; Shen Z; Abou-Gharbia MA; Bach AC; Harrison BL; Kagan N; Kleintop T; Magolda R; Marathias V; Robichaud AJ; Sabb AL; Zhang MY; Andree TH; Aschmies SH; Beyer C; Comery TA; Day M; Grauer SM; Hughes ZA; Rosenzweig-Lipson S; Platt B; Pulicicchio C; Smith DE; Sukoff-Rizzo SJ; Sullivan KM; Adedoyin A; Huselton C; Hirst WD
    J Med Chem; 2010 May; 53(10):4066-84. PubMed ID: 20443629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptor.
    Sternfeld F; Guiblin AR; Jelley RA; Matassa VG; Reeve AJ; Hunt PA; Beer MS; Heald A; Stanton JA; Sohal B; Watt AP; Street LJ
    J Med Chem; 1999 Feb; 42(4):677-90. PubMed ID: 10052975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of two 5-HT6 receptor antagonists on the rat liver: a molecular approach.
    Suter L; Haiker M; De Vera MC; Albertini S
    Pharmacogenomics J; 2003; 3(6):320-34. PubMed ID: 14610520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and development of a new class of potent, selective, orally active oxytocin receptor antagonists.
    Quattropani A; Dorbais J; Covini D; Pittet PA; Colovray V; Thomas RJ; Coxhead R; Halazy S; Scheer A; Missotten M; Ayala G; Bradshaw C; De Raemy-Schenk AM; Nichols A; Cirillo R; Tos EG; Giachetti C; Golzio L; Marinelli P; Church DJ; Barberis C; Chollet A; Schwarz MK
    J Med Chem; 2005 Dec; 48(24):7882-905. PubMed ID: 16302826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of an orally active, nonpeptidyl oxytocin antagonist.
    Pettibone DJ; Clineschmidt BV; Kishel MT; Lis EV; Reiss DR; Woyden CJ; Evans BE; Freidinger RM; Veber DF; Cook MJ
    J Pharmacol Exp Ther; 1993 Jan; 264(1):308-14. PubMed ID: 8423533
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insect chemosterilants. 1,2,4-Dithiazolium salts and related compounds as additives to housefly diet.
    Oliver JE; Brown RT; Fye RL; Borkovec AB
    J Agric Food Chem; 1973; 21(5):753-5. PubMed ID: 4733362
    [No Abstract]   [Full Text] [Related]  

  • 38. Characterization of receptors mediating contraction of the rat isolated small mesenteric artery and aorta to arginine vasopressin and oxytocin.
    Stam WB; Van der Graaf PH; Saxena PR
    Br J Pharmacol; 1998 Oct; 125(4):865-73. PubMed ID: 9831926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Gly/Ala switch contributes to high affinity binding of benzoxazinone-based non-peptide oxytocin receptor antagonists.
    Hawtin SR; Ha SN; Pettibone DJ; Wheatley M
    FEBS Lett; 2005 Jan; 579(2):349-56. PubMed ID: 15642343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oxytocin receptors: ligand binding, signalling and cholesterol dependence.
    Gimpl G; Reitz J; Brauer S; Trossen C
    Prog Brain Res; 2008; 170():193-204. PubMed ID: 18655883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.